Synonyms: Dojolvi® | UX-007 | UX007
triheptanoin is an approved drug (FDA (2020))
Compound class:
Synthetic organic
Comment: Triheptanoin is a medium-chain triglyceride that is administered as a rescue therapeutic in patients with long-chain fatty acid oxidation disorders [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2020) |
IUPAC Name ![]() |
2,3-di(heptanoyloxy)propyl heptanoate |
International Nonproprietary Names ![]() |
|
INN number | INN |
10893 | triheptanoin |
Synonyms ![]() |
Dojolvi® | UX-007 | UX007 |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL4297585 |
DrugBank Ligand | DB11677 |
GtoPdb PubChem SID | 440816800 |
PubChem CID | 69286 |
Search Google for chemical match using the InChIKey | PJHKBYALYHRYSK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | PJHKBYALYHRYSK |
Search PubMed clinical trials | triheptanoin |
Search PubMed titles | triheptanoin |
Search PubMed titles/abstracts | triheptanoin |
UniChem Compound Search for chemical match using the InChIKey | PJHKBYALYHRYSK-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | PJHKBYALYHRYSK-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Triheptanoin (links to external site)
Cat. No. HY-W013136 |